A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease
<p><strong>Background</strong> Bulk cancer and minimal residual disease (MRD) are characterised by different molecular drivers and therefore necessitate different therapeutic strategies. However, there are currently no 3D models that can faithfully recapitulate MRD ex vivo for ther...
主要な著者: | Yang, X, Artibani, M, Jin, Y, Aggarwal, A, Zhang, Y, Munoz-Galvan, S, Mikhailova, E, Rai, L, Mukherjee, N, Krishna Kumar, R, Albukhari, A, Zhou, L, Ahmed, AA, Bayley, H |
---|---|
フォーマット: | Internet publication |
言語: | English |
出版事項: |
2023
|
類似資料
-
3D Microtumours fabricated by microfluidics: applications in ovarian cancer
著者:: Yang, X
出版事項: (2023) -
Role of immunotherapy in ovarian cancer: a narrative review
著者:: Romanchik, D, 等
出版事項: (2022) -
Retraction Note: Visualising the dynamics of live pancreatic microtumours self-organised through cell-in-cell invasion
著者:: Yukiko Miyatake, 等
出版事項: (2024-10-01) -
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
著者:: Artibani, M, 等
出版事項: (2021) -
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
著者:: Mara Artibani, 等
出版事項: (2021-06-01)